XETRA - Delayed Quote EUR
Eli Lilly and Company (LLY.DE)
746.80
+23.10
+(3.19%)
At close: April 24 at 5:35:41 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 18 | 15 | 28 | 26 |
| Avg. Estimate | 12.72B | 14.35B | 59.52B | 71.64B |
| Low Estimate | 12.39B | 13.86B | 57.95B | 65.07B |
| High Estimate | 13.16B | 14.61B | 62.08B | 79.59B |
| Year Ago Sales | 8.77B | 11.3B | 45.04B | 59.52B |
| Sales Growth (year/est) | 45.09% | 26.92% | 32.14% | 20.36% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LLY.DE | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Initiated | Cantor Fitzgerald: Overweight | 4/22/2025 |
| Maintains | Guggenheim: Buy to Buy | 4/14/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 4/9/2025 |
| Upgrade | Goldman Sachs: Neutral to Buy | 4/8/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 3/5/2025 |
| Maintains | Truist Securities: Buy to Buy | 2/3/2025 |
Related Tickers
GS71.DE GSK plc
16.43
+1.33%
IDP.DE Biogen Inc.
105.50
+1.49%
ZEG.DE AstraZeneca PLC
122.30
+1.03%
PFE.DE Pfizer Inc.
20.04
+1.78%
JNJ.DE Johnson & Johnson
136.32
-0.16%
GS70.SG GSK PLC
31.60
-1.25%
C43.DE Cosmo Pharmaceuticals N.V.
50.00
0.00%
GIS.DE Gilead Sciences, Inc.
94.56
+1.74%
ORINY Orion Oyj
28.25
0.00%
SNW.DE Sanofi
93.33
-0.07%